![]() |
Volumn 122, Issue 4, 2008, Pages 828-829
|
Montelukast and emotional well-being as a marker for depression: Results from 3 randomized, double-masked clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUTICASONE;
MONTELUKAST;
PLACEBO;
SALMETEROL;
THEOPHYLLINE;
ADD ON THERAPY;
ASTHMA;
CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
DEPRESSION;
DRUG EFFICACY;
EMOTION;
HUMAN;
LETTER;
LOW DRUG DOSE;
MONOTHERAPY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
STRUCTURED QUESTIONNAIRE;
TREATMENT DURATION;
ACETATES;
ADULT;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
DEPRESSION;
DOUBLE-BLIND METHOD;
EMOTIONS;
FEMALE;
HUMANS;
MALE;
MULTICENTER STUDIES AS TOPIC;
QUALITY OF LIFE;
QUINOLINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SUICIDE;
|
EID: 53049100875
PISSN: 00916749
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaci.2008.07.012 Document Type: Letter |
Times cited : (32)
|
References (9)
|